Letters to the editors (multiple letters)

Tropical Medicine and International Health

Volumn 6, Issue 4, 2001, Pages 324-325

  Patrick Kachur, S ^a,b,c,d,e   Abdulla, Salim ^a,b,c,d,e   Barnes, Karen ^a,b,c,d,e   Mshinda, Hassan ^a,b,c,d,e   Durrheim, David ^a,b,c,d,e   Kitua, Andrew ^a,b,c,d,e   Bloland, Peter ^a,b,c,d,e  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b IFAKARA HEALTH INSTITUTE   (Tanzania)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d Ministry of Health   (South Africa)

^e NATIONAL INSTITUTE OF MEDICAL RESEARCH   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISIN; CHLOROQUINE; PYRIMETHAMINE; SULFADOXINE; ARTEMISININ; ARTEMISININ DERIVATIVE; SESQUITERPENE;

BLOOD TRANSFUSION; DISEASE TRANSMISSION; EXPIRATION DATE; HEALTH CARE POLICY; HEALTH SERVICE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; IMMUNOBLOTTING; LETTER; MALARIA; SENSITIVITY AND SENSIBILITY; CLINICAL TRIAL; HUMAN; NOTE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2;

ANTIMALARIALS; ARTEMISININS; CLINICAL TRIALS; HUMANS; MALARIA; SESQUITERPENES;

EID: 0035037922     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.2001.0719a.x     Document Type: Letter

References (0)